Literature DB >> 2741980

Assessment of tissue iron overload by nuclear magnetic resonance imaging.

D L Johnston1, L Rice, G W Vick, T D Hedrick, R Rokey.   

Abstract

PURPOSE: The ability of stored intracellular iron to enhance magnetic susceptibility forms the basis by which tissue iron can be detected by nuclear magnetic resonance (NMR) imaging. We used this technique to assess myocardial, spleen, and liver iron content in patients with known or suspected iron overload disorders. PATIENTS AND METHODS: Spin echo NMR images were obtained in 30 patients; 20 had chronic anemias treated by multiple blood transfusions, five had idiopathic hemochromatosis, and five had non-hemochromatotic liver disease with elevated serum ferritin levels and no stainable iron on liver biopsy. The acquisition of oblique images through the short axis of the left ventricle permitted assessment of left ventricular function, while demonstrating the liver and spleen on the same image. Iron content was assessed using a signal intensity ratio of organ (spleen, liver, or myocardium) to skeletal muscle.
RESULTS: In patients with multiple blood transfusions, iron content was highest in liver, followed by the spleen. Significant iron overload was detected in the myocardium of only one patient. Left ventricular systolic wall thickening was normal in patients receiving multiple blood transfusions. Two patients with treated idiopathic hemochromatosis had normal signal intensity ratios, and three untreated patients had evidence of significant deposits of iron in the liver and spleen as indicated by a reduction in signal intensity ratios (0.2 +/- 0.01 and 0.9 +/- 0.01, respectively). Five patients with non-hemochromatotic liver disease and high serum ferritin levels had normal signal intensity ratios by NMR imaging.
CONCLUSION: NMR imaging is a useful method of detecting tissue iron and distinguishing disease due to iron overload. Myocardial iron deposition is a late event, occurring after accumulation of iron in the spleen and liver.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2741980     DOI: 10.1016/s0002-9343(89)80481-4

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  14 in total

1.  Indirect evidence for the potential ability of magnetic resonance imaging to evaluate the myocardial iron content in patients with transfusional iron overload.

Authors:  P D Jensen; F T Jensen; T Christensen; L Heickendorff; L G Jensen; J Ellegaard
Journal:  MAGMA       Date:  2001-05       Impact factor: 2.310

Review 2.  Evaluation of myocardial iron overload using magnetic resonance imaging.

Authors:  Sophie Mavrogeni
Journal:  Blood Transfus       Date:  2009-07       Impact factor: 3.443

Review 3.  The emerging role of MRI in the diagnosis and management of cardiomyopathies.

Authors:  Carlos Eduardo Rochitte; Eduardo Marinho Tassi; Afonso Akio Shiozaki
Journal:  Curr Cardiol Rep       Date:  2006-02       Impact factor: 2.931

Review 4.  Transplantation in patients with iron overload: is there a place for magnetic resonance imaging? : Transplantation in iron overload.

Authors:  Sophie Mavrogeni; Genovefa Kolovou; Boris Bigalke; Angelos Rigopoulos; Michel Noutsias; Stamatis Adamopoulos
Journal:  Heart Fail Rev       Date:  2018-03       Impact factor: 4.214

Review 5.  Iron overload cardiomyopathy: better understanding of an increasing disorder.

Authors:  Pradeep Gujja; Douglas R Rosing; Dorothy J Tripodi; Yukitaka Shizukuda
Journal:  J Am Coll Cardiol       Date:  2010-09-21       Impact factor: 24.094

6.  Cardiac iron overload in thalassemic patients: an endomyocardial biopsy study.

Authors:  T Lombardo; C Tamburino; G Bartoloni; M L Morrone; V Frontini; F Italia; S Cordaro; A Privitera; V Calvi
Journal:  Ann Hematol       Date:  1995-09       Impact factor: 3.673

7.  Respiratory function in patients with thalassaemia major: relation with iron overload.

Authors:  A M Li; D Chan; C K Li; E Wong; Y L Chan; T F Fok
Journal:  Arch Dis Child       Date:  2002-10       Impact factor: 3.791

Review 8.  Iron overload cardiomyopathies: new insights into an old disease.

Authors:  P Liu; N Olivieri
Journal:  Cardiovasc Drugs Ther       Date:  1994-02       Impact factor: 3.727

9.  Myocardial iron deposition in beta-thalassemia studied by magnetic resonance imaging.

Authors:  S I Mavrogeni; T Maris; A Gouliamos; L Vlahos; D T Kremastinos
Journal:  Int J Card Imaging       Date:  1998-04

10.  Effect of iron overload on exercise capacity in thalassemic patients with heart failure.

Authors:  Sophie Mavrogeni; Efstathios Gotsis; Dimitrios Verganelakis; Eleni Berdousis; Athanasios Dritsas; Genovefa Kolovou; Panagiotis Toulas; Vassilios Ladis
Journal:  Int J Cardiovasc Imaging       Date:  2009-08-13       Impact factor: 2.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.